Measuring the Quality of Life of Patients with Diabetic Retinopathy in Northern India: a Comparison of Generic and Vision Specific Instruments

Overview

Journal Health Qual Life Outcomes

Publisher Biomed Central

Specialty Public Health

Date 2025 Feb 21

PMID 39985016

Authors

Neha Purohit

Aarti Goyal

Vishali Gupta

Parul Chawla Gupta

Prakash Singh

Shankar Prinja

Affiliations

Soon will be listed here.

Abstract

Background: Estimation of health-related quality of life (HRQoL) in diabetic retinopathy (DR) patients is important to assess the impact of disease, to monitor the treatment outcomes, and conduct health technology assessments. The study aimed to measure the HRQoL in DR patients using the generic as well as disease specific instruments, identify the determinants of HRQoL, empirically investigate the concurrent validity between the QoL instruments, and to develop statistical approaches to map NEI-VFQ-25 (National Eye Institute- Visual Function Questionnaire- 25) composite score based on EQ-5D-5 L (EuroQol 5-dimensions 5-levels) utility values.

Methods: A facility based cross-sectional study was carried out to measure the HRQoL of 300 DR patients using EQ-5D-5 L, EuroQol visual analogue scale (EQ-VAS), and NEI-VFQ-25 instruments. Mean HRQoL scores, along with DR state specific and visual acuity specific utility values were analysed. Pearson correlation coefficient was used to ascertain concurrent validity between NEI-VFQ-25 composite score and its sub-scale scores, EQ-5D-5L index value, and EQ-VAS score. Lastly, we evaluated statistical models using predictor sets based on the EQ-5D-5 L utility scores to estimate NEI-VFQ-25 scores.

Results: The mean EQ-5D-5 L utility value for DR patients was 0.69 (95% CI: 0.65-0.73). The mean NEI-VFQ-25 composite score and EQ-VAS score were 61.1 (95% CI: 57.5-64.5), and 67.6 (95% CI: 65.6-69.5), respectively. Both EQ-5D-5 L and EQ-VAS had a strong concurrent validity with NEI-VFQ-25 composite score. 'Tobit regression with log of composite score' was assessed to the preferred model to predict the NEI-VFQ-25 composite score using EQ-5D-5L utility values.

Conclusion: Diabetic retinopathy has a decremental impact on quality of life, which increases with severity in vision loss. Both generic as well as disease-specific outcome measures are equally reliable to determine quality of life of patients with DR. The EQ-5D-5 L can be utilized for measurement of HRQoL in DR in clinical settings to optimize time of clinicians, with further derivation of NEI-VFQ-25 values through application of the crosswalk algorithm for predicting vision- related QoL.

References

Jyani G, Prinja S, Garg B, Kaur M, Grover S, Sharma A . Health-related quality of life among Indian population: The EQ-5D population norms for India. J Glob Health. 2023; 13:04018. PMC: 9936451. DOI: 10.7189/jogh.13.04018. View

Gandhi M, Ang M, Teo K, Wong C, Wei Y, Tan R . A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery. Eur J Health Econ. 2020; 21(4):501-511. DOI: 10.1007/s10198-019-01156-w. View

Payakachat N, Summers K, Pleil A, Murawski M, Thomas 3rd J, Jennings K . Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration. Qual Life Res. 2009; 18(7):801-13. DOI: 10.1007/s11136-009-9499-6. View

Deshpande P, Rajan S, Sudeepthi B, Abdul Nazir C . Patient-reported outcomes: A new era in clinical research. Perspect Clin Res. 2011; 2(4):137-44. PMC: 3227331. DOI: 10.4103/2229-3485.86879. View

Arnold D, Girling A, Stevens A, Lilford R . Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis. BMJ. 2011; 339:b2688. PMC: 2714630. DOI: 10.1136/bmj.b2688. View

Sharma D, Prinja S, Aggarwal A, Rajsekar K, Bahuguna P . Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment. Lancet Reg Health Southeast Asia. 2023; 16:100241. PMC: 10485782. DOI: 10.1016/j.lansea.2023.100241. View

Papageorgiou S . On correlation coefficients and their interpretation. J Orthod. 2022; 49(3):359-361. PMC: 9420886. DOI: 10.1177/14653125221076142. View

Gabrielian A, Hariprasad S, Jager R, Green J, Mieler W . The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life. Eye (Lond). 2009; 24(1):29-35. DOI: 10.1038/eye.2009.56. View

Deswal J, Narang S, Gupta N, Jinagal J, Sindhu M . To study the impact of diabetic retinopathy on quality of life in Indian diabetic patients. Indian J Ophthalmol. 2020; 68(5):848-853. PMC: 7350471. DOI: 10.4103/ijo.IJO_1553_19. View

10.

Tung T, Chen S, Lee F, Liu J, Lin C, Chou P . A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract. 2005; 68(3):265-73. DOI: 10.1016/j.diabres.2004.10.003. View

11.

Zare F, Ameri H, Madadizadeh F, Reza Aghaei M . Health-related quality of life and its associated factors in patients with type 2 diabetes mellitus. SAGE Open Med. 2021; 8:2050312120965314. PMC: 8107944. DOI: 10.1177/2050312120965314. View

12.

Lloyd A, Loftus J, Turner M, Lai G, Pleil A . Psychometric validation of the Visual Function Questionnaire-25 in patients with diabetic macular edema. Health Qual Life Outcomes. 2013; 11:10. PMC: 3599421. DOI: 10.1186/1477-7525-11-10. View

13.

Pawar S, Parkar A, Menon S, Desai N, Namrata D, Dole K . Assessment of quality of life of the patients with diabetic retinopathy using National Eye Institute Visual Functioning Questionnaire (VFQ-25). J Healthc Qual Res. 2021; 36(4):225-230. DOI: 10.1016/j.jhqr.2021.02.004. View

14.

Jyani G, Sharma A, Prinja S, Kar S, Trivedi M, Patro B . Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set. Value Health. 2022; 25(7):1218-1226. DOI: 10.1016/j.jval.2021.11.1370. View

15.

Polack S, Alavi Y, Rachapalle Reddi S, Kulothungan V, Kuper H . Utility values associated with diabetic retinopathy in Chennai, India. Ophthalmic Epidemiol. 2014; 22(1):20-7. DOI: 10.3109/09286586.2014.885057. View

16.

Lloyd A, Nafees B, Gavriel S, Rousculp M, Boye K, Ahmad A . Health utility values associated with diabetic retinopathy. Diabet Med. 2008; 25(5):618-24. DOI: 10.1111/j.1464-5491.2008.02430.x. View

17.

Kontodimopoulos N, Pappa E, Chadjiapostolou Z, Arvanitaki E, Papadopoulos A, Niakas D . Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications. Eur J Health Econ. 2010; 13(1):111-20. DOI: 10.1007/s10198-010-0290-y. View

18.

Kay S, Ferreira A . Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores. Ophthalmic Epidemiol. 2014; 21(2):66-78. DOI: 10.3109/09286586.2014.888456. View

19.

Khoo K, Man R, Rees G, Gupta P, Lamoureux E, Fenwick E . The relationship between diabetic retinopathy and psychosocial functioning: a systematic review. Qual Life Res. 2019; 28(8):2017-2039. DOI: 10.1007/s11136-019-02165-1. View

20.

Shah V, Gupta S, Shah K, Vinjamaram S, Chalam K . TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD. Ophthalmic Epidemiol. 2004; 11(1):43-51. DOI: 10.1076/opep.11.1.43.26436. View